Dave Clissold speaking at EU and US Regulatory Issues for IP Professionals conference

Orphan Exclusivity . . . continued Regulatory Strategy and Appropriate Interaction with Authorities The Regulatory Frameworks for Advanced Therapy Medicinal Products

When

February 4, 2013

Dave Clissold speaking on:

   Orphan Exclusivity . . . continued

   Regulatory Strategy and Appropriate Interaction with Authorities

   The Regulatory Frameworks for Advanced Therapy Medicinal Products

at the EU and US Regulatory Issues for IP Professionals conference.

Geneva